Please assess the completion status of the following clinical trial:

Trial Title: Feeding Malnourished Children Different Types of Fatty Acids to Promote Neurocognitive Development

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* 6-59 months~* An acceptable appetite defined by the ability to consume 30 grams RUTF within 20 minutes~* Mid Upper Arm Circumference \<11.5 cm, weight-for-height z-score \< -3, or bilateral pitting edema on the dorsum of the feet~Exclusion Criteria:~* Participation in any other ongoing study or supplementary feeding program~* Children with a chronic medical condition, including cerebral palsy, static encephalopathy, congenital heart disease, gastrointestinal disease, or peanut allergy

- Gender: ALL
- Minimum Age: 6 Months
- Maximum Age: 59 Months
- Healthy Volunteers: f

Study Arms:
- Conventional RUTF (S-RUTF) (Type: ACTIVE_COMPARATOR): This is the control group for the study, which will receive the international standard of care therapeutic food. S-RUTF is made with conventional peanuts, which are inherently high in omega-6 linoleic acid.
- High oleic RUTF (HO-RUTF) (Type: EXPERIMENTAL): The treatment provided to children randomized to this arm of the study includes nutritional content comparable to S-RUTF with the exception of a low lineoleic acid/high oleic acid ratio formulated with high oleic content peanuts.
- DHA-supplemented HO-RUTF (D-HO-RUTF) (Type: EXPERIMENTAL): The treatment provided to children randomized to this arm of the study mirrors that provided by HO-RUTF with that addition of supplemental DHA at a level higher than attainable with optimal precursors.

Based on this trial design, predict the completion outcome and termination type (if applicable).